
Background: Cardiovascular diseases are a major cause of global morbidity and mortality, with a high burden in low- and middle-income countries (LMICs). Limited access to cardiac catheterisation services contributes to poor health outcomes. This study reviewed catheterisation procedures, indications and outcomes in a government-owned Nigerian tertiary hospital. Materials and Methods: A retrospective review of all diagnostic and interventional procedures performed at the Lagos State University Teaching Hospital cardiac catheterisation laboratory between July 2022 and October 2025 was conducted. Data on patient demographics, procedures, anaesthetic techniques, indications and outcomes were extracted from the laboratory register and analysed using descriptive statistics. Results: A total of 588 procedures were performed. Mean patient age was 57.09 ± 16.62 years, with a slight male predominance (52.7%). Most procedures were conducted under local anaesthesia (72.6%). The most frequent procedures were inferior vena cava filter insertion (18.5%), coronary angiography (16.2%), percutaneous coronary intervention (15.8%) and pacemaker implantation (14.5%). Commonest indications were acute coronary syndrome (30.8%), venous thromboembolism (21.6%) and arrhythmias/conduction abnormalities (16.2%). Procedural volume increased progressively over the study period, with gradual expansion from predominantly diagnostic to more therapeutic procedures. Procedural success was high across all categories, with three deaths recorded (0.51%). Conclusion: This study demonstrates that cardiac catheterisation services can be safely and effectively delivered in a government-owned tertiary hospital within an LMIC. Strategic investment in establishing and expanding cardiac catheterisation is imperative to strengthen cardiovascular care delivery across the LMICs.
Introduction: Chronic viral hepatitis remains a major global health concern, particularly in sub-Saharan Africa, where Nigeria bears a high disease burden. Despite the World Health Organisation’s (WHO’s) target to eliminate hepatitis B virus (HBV) and hepatitis C virus (HCV) infections by 2030, testing and treatment coverage in Nigeria remain suboptimal. This study assessed HBV and HCV prevalence in a community in North Central Nigeria to inform local elimination efforts. Materials and Methods: A cross-sectional survey was conducted during a medical outreach at the Emir’s palace in Shabu, Nasarawa State, in October 2022. A total of 117 participants, including royal family members, village heads and nearby residents, were screened for HBV and HCV using rapid diagnostic test kits. Data on age, gender, and test results were analysed using Statistical Package for the Social Sciences version 27, with significance set at a P value of < 0.05. Results: Amongst 117 participants (median age: 45 years; 58.1% male), the prevalence of hepatitis B surface antigen (HBsAg) and HCV antibodies was 8.5% each. Overall, 15.4% had either infection, whereas 0.9% were co-infected. Participants positive for HBsAg were significantly younger than those negative (median age: 33 years vs. 47 years; P = 0.016). Conclusion: The prevalence of HBV and HCV in the community exceeds national averages, revealing persistent gaps in awareness and screening even amongst privileged populations. Targeted education, screening, and access to antiviral therapy are essential to achieve the WHO elimination goals and promote equitable hepatitis control in Nigeria.
Background: Cancer treatment causes significant sexual dysfunction, yet this complication remains under-recognised in Nigerian oncology settings. This study assessed the prevalence, predictors and lived experiences of treatment-related sexual dysfunction among patients attending a tertiary cancer centre in Lagos, Nigeria. Materials and Methods: A concurrent mixed-methods design was employed. The quantitative component enrolled 330 adult cancer patients (64.8% female; mean age: 54.2 years) receiving active treatment at the Nigeria Sovereign Investment Authority-Lagos University Teaching Hospital Cancer Centre between September 2024 and August 2025. Sexual dysfunction was measured with the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Sexual Health 22-item. Logistic regression identified treatment-specific predictors. For the qualitative component, in-depth interviews were conducted with 30 purposively selected participants until data saturation; transcripts underwent thematic analysis using Braun and Clarke’s six-phase framework. Results: Vaginal dryness or dyspareunia was reported by 72% of female participants, and erectile dysfunction by 68% of male participants. Radiotherapy was the strongest predictor of sexual dysfunction (adjusted odds ratio [OR]: 3.2; 95% confidence interval [CI]: 1.8–5.6; P < 0.001), followed by chemotherapy (adjusted OR: 1.9; 95% CI: 1.1–3.4; P = 0.023). Qualitative analysis yielded three major themes: body image disturbance, partner communication breakdown and clinician–patient communication gaps. Conclusion: Sexual dysfunction is prevalent among Nigerian cancer patients and inadequately addressed in current practice. Culturally adapted, multidisciplinary interventions, including clinician training and structured sexual health screening, are urgently needed to integrate sexual health into cancer survivorship care in low-resource settings.
Background: Health-related quality of life (HRQoL) is a comprehensive assessment of the physical, mental and social well-being of individuals. It can be impacted negatively by obesity. Some studies in Nigeria suggest a high prevalence of adolescent obesity and its attendant medical consequences. However, the effect of obesity on the HRQoL has not been explored amongst adolescents in Abeokuta, Nigeria. Materials and Methods: A school-based cross-sectional study was carried out amongst 1010 secondary school students in Abeokuta using a multi-stage sampling method. The participants were categorised into obese and normal-weight groups based on their body mass index using the World Health Organisation charts. The HRQoL was assessed using a self-administered Paediatric Quality of Life Inventory 4.0 Generic Core Scales questionnaire. Data analysis was done using Statistical Package for the Social Sciences version 23. The Mann–Whitney U test was used to compare data obtained from the two groups. Results: The scores of the male obese participants in the social and school functioning domains were significantly higher than those of their normal-weight counterparts [85.0 (65.0–100.0) vs. 75.0 (55.0–100.0); P < 0.001] and [90.0 (75.0–100.0) vs. 85.0 (70.0–100.0); P = 0.010], respectively. Obese adolescents from high socio-economic status had higher scores than those in the normal-weight participants in the physical functioning domain [87.5 (75.0–100.0) vs. 81.3 (68.8–93.8); P = 0.044], respectively. Conclusions: This study demonstrates better HRQoL scores in the obese adolescents than in their normal-weight counterparts in Abeokuta.
Background: Surgical site infection (SSI) remains an important cause of postoperative morbidity after heart procedures and is associated with prolonged recovery and increased healthcare utilisation. Prospective data evaluating both determinants and early postoperative impacts within the same cohort are limited. Materials and Methods: A prospective cohort study was conducted on 271 consecutive patients who underwent heart procedures at Institutes of Cardiovascular Diseases, Madras Medical Mission, Chennai, Tamil Nadu, India, a tertiary cardiac centre. Procedures included surgical myocardial revascularisation, valvular intervention, congenital cardiac procedures and combined surgeries. SSI surveillance was performed for 30 days using Centers for Disease Control and Prevention criteria. Logistic regression analysis was used to evaluate predictors of infection. Postoperative outcomes, including reintubation, re-exploration, blood transfusion, hospital stay and in-hospital mortality, were compared between patients with and without SSI. Results: SSI developed in 24 patients, yielding an incidence of 8.9%. Severe ventricular dysfunction (left ventricular ejection fraction <35%) remained independently associated with infection following multivariable adjustment (adjusted odds ratio = 4.11, 95% confidence interval: 1.31–12.9, P = 0.015). Patients who developed SSI experienced longer hospitalisation and higher rates of postoperative interventions, including reintubation, re-exploration and blood transfusion. Mortality occurred more frequently in infected patients, although the number of events was limited. Conclusion: SSI is a clinically significant complication of cardiac surgery. Severe ventricular dysfunction was the strongest independent predictor of infection in this cohort study. Patients with severe ventricular dysfunction may benefit from closer perioperative surveillance and postoperative optimisation.